| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,789 |
13,221 |
$755K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,025 |
2,426 |
$188K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,456 |
4,872 |
$104K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,718 |
1,480 |
$61K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
135 |
125 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,563 |
1,900 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
789 |
545 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,127 |
3,271 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,591 |
2,470 |
$3K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,024 |
797 |
$2K |
| 20552 |
|
163 |
77 |
$2K |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
199 |
153 |
$736.96 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
184 |
64 |
$555.64 |
| 71046 |
Radiologic examination, chest; 2 views |
38 |
29 |
$513.70 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
39 |
28 |
$303.75 |
| 36415 |
Collection of venous blood by venipuncture |
80 |
65 |
$137.00 |
| 81003 |
|
604 |
425 |
$9.18 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
32 |
25 |
$2.76 |
| 99000 |
|
13 |
13 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
27 |
17 |
$0.00 |